恶性黑色素瘤。预后因素的多变量分析。 - Suppr

Suppr

超能文献

Malignant melanoma. A multivariate analysis of prognostic factors.

作者信息

Vollmer R T

出版信息

Pathol Annu. 1989;24 Pt 1:383-407.

PMID:2654844

Abstract

摘要

相似文献

Malignant melanoma. A multivariate analysis of prognostic factors.恶性黑色素瘤。预后因素的多变量分析。

Pathol Annu. 1989;24 Pt 1:383-407.

Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.皮肤恶性黑色素瘤局部复发患者的预后：一项基于人群的研究。

Cancer. 1997 Oct 15;80(8):1418-25.

Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.恶性黑色素瘤的预后变量和预后分组。来自Cox模型及分类与回归树分析的信息：一项基于意大利人群的研究。

Melanoma Res. 2006 Oct;16(5):429-33. doi: 10.1097/01.cmr.0000222602.80803.e1.

The role of microsatellites as a prognostic factor in primary malignant melanoma.微卫星作为原发性恶性黑色素瘤预后因素的作用。

Arch Dermatol. 2005 Jun;141(6):739-42. doi: 10.1001/archderm.141.6.739.

Hazard rate of recurrence in patients with malignant melanoma.

Aerosp Med. 1971 Nov;42(11):1219-25.

Microvessel density for melanoma prognosis.用于黑色素瘤预后评估的微血管密度

Histopathology. 2005 Aug;47(2):186-94. doi: 10.1111/j.1365-2559.2005.02193.x.

Independent prognostic importance of vascular invasion in nodular melanomas.结节性黑色素瘤中血管侵犯的独立预后重要性。

Cancer. 1996 Sep 15;78(6):1211-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C.

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.蛋白S-100β、黑色素瘤抑制活性以及酪氨酸酶/MART-1逆转录聚合酶链反应在高危黑色素瘤患者随访中的诊断价值及预后意义

Cancer. 2003 Apr 1;97(7):1737-45. doi: 10.1002/cncr.11250.

[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].[黑色素瘤前哨淋巴结活检：300例患者的预后价值及缺点]

Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1845-51.

Predictive value of different prognostic factors in breast cancer recurrences: multivariate analysis using a logistic regression model.

Anticancer Res. 2001 Nov-Dec;21(6A):4105-8.

引用本文的文献

Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study.基于临床和病理特征的皮肤黑色素瘤预后：一项基于人群的研究。

Front Oncol. 2021 Nov 16;11:737399. doi: 10.3389/fonc.2021.737399. eCollection 2021.

Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.高危可切除黑色素瘤的临床病理特征、分期和当前治疗方法。

J Natl Cancer Inst. 2020 Sep 1;112(9):875-885. doi: 10.1093/jnci/djaa012.

The prognostic significance of microsatellites in cutaneous melanoma.微卫星在皮肤黑色素瘤中的预后意义。

Mod Pathol. 2020 Jul;33(7):1369-1379. doi: 10.1038/s41379-020-0500-9. Epub 2020 Feb 13.

Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain.组织学溃疡作为皮肤黑色素瘤的预后因素：西班牙 423 例研究。

Clin Transl Oncol. 2012 Mar;14(3):237-40. doi: 10.1007/s12094-012-0790-6.

Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?黑色素瘤患者初级护理的预后参数：黑色素瘤真正的风险是什么？

J Skin Cancer. 2011;2011:521947. doi: 10.1155/2011/521947. Epub 2011 Oct 11.

Staging and prognosis of cutaneous melanoma.皮肤黑色素瘤的分期与预后

Surg Oncol Clin N Am. 2011 Jan;20(1):1-17. doi: 10.1016/j.soc.2010.09.007.

Treatment and outcomes of melanoma in acral location in Korean patients.韩国患者肢端黑素瘤的治疗和结局。

Yonsei Med J. 2010 Jul;51(4):562-8. doi: 10.3349/ymj.2010.51.4.562.

The changing prognosis of melanoma.黑色素瘤不断变化的预后。

Curr Oncol Rep. 2000 Jul;2(4):322-8. doi: 10.1007/s11912-000-0025-9.

ACP best practice no 162. The histological reporting of melanoma. Association of Clinical Pathologists.临床病理学家协会最佳实践第162号。黑色素瘤的组织学报告。

J Clin Pathol. 2000 Aug;53(8):587-90. doi: 10.1136/jcp.53.8.587.

Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.临床I期皮肤黑色素瘤中CD44和透明质酸水平降低与不良预后相关。

Am J Pathol. 2000 Sep;157(3):957-65. doi: 10.1016/S0002-9440(10)64608-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验